Introduction
Liver cirrhosis, which is usually a long-term consequence of chronic hepatic injury caused by alcohol abuse or hepatitis virus infection, is characterized by extensive fibrous scarring of the liver. Advanced cirrhosis is generally irreversible and is often associated with variceal hemorrhage or development of hepatocellular carcinoma. Hence, liver cirrhosis is a major cause of morbidity and mortality worldwide.
An effective treatment, capable of counteracting cirrhosis, has not yet been developed. Hypothetically, therapeutic strategies must rely on achieving liver regeneration and increased extracellular matrix degradation (1) .
Hepatocyte growth factor (HGF), originally identified and cloned as a mitogenic protein for hepatocytes, exerts diverse cellular responses through c-Met receptor tyrosine kinase (2, 3) . HGF is a pluripotent growth factor displaying a remarkable ability to promote tissue repair and organ regeneration after injury (4) . HGF is a potent agent for acceleration of tissue regeneration following an acute insult, as well as amelioration of tissue fibrosis and dysfunction in chronic conditions (5) (6) (7) .
Based on the trophic roles of HGF in tissue regeneration and protection, HGF is currently discussed as an attractive therapeutic agent for fatal liver diseases. Approaches to address the therapeutic potential of HGF have already been made using a variety of experimental models, and indeed there are promising results that administration of HGF leads to improvement in hepatic cirrhosis (8, 9) .
Nevertheless, although the concept of therapeutical HGF application might be plausible, studies have also shown that a cirrhotic liver following hepatic resection regenerates very slowly in comparison with a normal liver (10) (11) (12) . This might be in contradiction to the statements given above, as HGF has been found to be excessively increased in the cirrhotic (13, 14) . It therefore seems to be unclear why external supplements of HGF should lead to recovery from cirrhosis. We speculated that c-Met receptors might not respond adequately to HGF in the cirrhotic liver. To verify this, c-Met expression and HGF-induced phosphorylation were analyzed using hepatocytes cultured under de-differentiation inducing conditions, i.e. in a growth factor enriched extracellular milieu. A characteristic feature of fibrosis/cirrhosis is disturbance of the liver architecture. To mimic this process, we compared hepatocytes with an intact three-dimensional architecture to those plated on a two-dimensional matrix.
Materials and methods
Isolation of rat hepatocytes. The study protocol was approved by the local ethics committee and the governmental board for the care of animal subjects (Regierungspräsidium Darmstadt, Germany). Primary hepatocytes were isolated from livers of male Sprague-Dawley Rats (body weight: 400-500 g). Isolation of hepatocytes was performed by a two-step collagenase perfusion technique as previously described (16) . Briefly, the portal vein was flushed for 15-20 min with EGTA-solution (HBSS w/o Ca 2+ and Mg 2+ , 0.5 mM EGTA) at 37˚C, at a flow rate which was increased from 20 ml/min to 40 ml/min (Masterflex pump, Novodirekt, Kehl am Main, Germany). The liver was then perfused under recirculation with collagenasesolution (HBSS w/o Ca 2+ and Mg 2+ , 5 mM CaCl 2 , 0.075% collagenase type IV) at the same temperature, at a flow rate which was increased from 40 to 80 ml/min (incubation: 10-30 min).
At the end of the perfusion, the non-perfused part of the liver tissue was discarded and liver cells from the well-perfused part were scraped out and gently dispersed in cold HBSS, enriched with 10% HEPES-buffer and 50 μg/ml gentamycin. The cell suspension was filtered through a 70-mm nylon mesh filter and centrifuged at 28 g (5 min). The pellet was resuspended in DMEM/Ham's F12 medium and overlayed onto Percoll gradient with a density of 1.065 g/ml (Percoll, Pharmacia), followed by low speed Bouyant-gradient centrifugation of the liver-cell-suspension at 50 x g.
The cell-isolation yielded a mean number of 2.3x10 8 primary rat hepatocytes (HC) (minimum 2.8x10 6 , maximum 4.6x10 8 HC) with a cell viability of 89±9%, measured by trypan-blue dye exclusion. Isolated hepatocytes were resuspended in complete culture medium, described elsewhere, and seeded at a final density of 1.8x10 5 cells/cm 2 into multi-well plates coated with extracellular matrices to enable confluent monolayers.
Preparation of two-dimensional collagen matrix. Each well was coated with 25 μg/cm 2 of Collagen type I, derived from bovine skin (Seromed-Biochrom, Berlin, Germany). After incubation for 1 h at 37˚C, each well was washed twice with PBS (Gibco) before plating the hepatocytes.
Preparation of sandwich-cultured hepatocytes.
To prepare a three-dimensional collagen gel configuration (3D gel), the culture medium was removed after 24 h (37˚C, 5% CO 2 ) and replaced by the collagen-sandwich-solution. The collagen sandwich solution was prepared by diluting 1 part 10X Dulbecco's modified Eagle's medium (DMEM) and 1 part 0.1-0.2 M NaOH in 10X HEPES buffer in 8 parts of collagen I (3 mg/ml). The collagen overlays were incubated for 6 h (37˚C, 5% CO 2 ) to allow collagen to gel before the addition of hepatocyte culture medium. The culture medium was changed after the first 24 h and thereafter every 48 h.
Composition of the culture media and hepatocyte incubation.
Hepatocytes were cultured continuously either in a differentiation medium representing physiologically healthy hepatocytes, or cultivated in a de-differentiation medium, an enriched extracellular milieu which occurs during cirrhotic processes. Initiation of this culture system and the relevance of the medium composition for the hepatocellular differentiation status have been described in detail in the previous report (17) .
Both media consisted of DMEM (Invitrogen, Karlsruhe, Germany), supplemented with 5% pooled human serum (kindly provided by the blood bank of the Red Cross, Frankfurt, Germany), 20 mM HEPES, and 50 μg/ml gentamycin (Gibco/ BRL, Karlsruhe, Germany). Differentiation medium was enriched with nicotinamide, insulin, transferrin, selenium, and dexamethasone. De-defferentiation medium was deprived of hormones but instead enriched with the mitogens, EGF, HGF, and granulocyte-macrophage colony-stimulating factor (GM-CSF). The full description of both media is shown in Table I .
Ursodeoxycholic acid and tauroursodeoxycholic acid were obtained from Falk, Freiburg, Germany and added to a specified culture medium.
Analysis of surface c-Met and ASGPr expression by flow cytometry.
Hepatocyte-specific ASGPr was necessary to control the differentiation status of the cells (15, 19) . For the analysis of c-Met receptor, hepatocytes were washed in PBS without Ca 2+ or Mg 2+ followed by 5-10-min incubation with ice-cold 0.02% EDTA solution (Seromed/Biochrom). The detached HC was centrifuged at 250 x g for 5 min, cell pellets were incubated with diluted anti c-met (rabbit, polyclonal, 1:100; Santa Cruz Biotechnology, Heidelberg, Germany) in PBS with 0.5% BSA for 60 min at 4˚C, HC were washed after incubation and further labeled with goat anti-rabbit FITC-IgG (Dianova; 1:50) in PBS, 0.5% BSA for 30 min at 4˚C. For ASGPr analysis, HC were treated with Fix&Perm kit (An der Grub/Dianova, Hamburg, Germany) prior to intracellular staining. The detached HC were fixed with reagent A for 10 min, washed and incubated with reagent B together with diluted anti-ASGPr (rabbit, polyclonal, 1:100; kindly provided by U. Treichel, Essen) in PBS with 0.5% BSA for 60 min at 4˚C. HC were washed and incubated for 30 min at 4˚C with reagent B together with goat anti-rabbit-FITC-IgG (Dianova; 1:50) in PBS with 0.5% BSA. After extensive washing, immnunofluorescence was analyzed by a FACScan Flow cytometer (Becton-Dickinson, Heidelberg, Germany) using cellquest software. The receptor expression is given as MFI (Mean Fluorescence Intensity) [FL-1H (log) channel histogram analysis; 1x10 4 
cells/scan].
Western blot analysis. Hepatocyte cultures were rinsed briefly with ice-cold PBS and lysed for 5 min in lysis buffer (50 mM HEPES, 200 mM NaCl, 0.2 mM MgSO 4 (Merck), 0.4 mM PMSF, 2% Triton-X-100, 10 μg/ml leupeptine, 10 μg/ml aprotinine, 0.02% soybean-trypsin-inhibitor, and 0.2 mM ortho-vanadate (all Sigma-Aldrich). The cell lysates were centrifuged for 10 min at 12.000 U/min at 4˚C. The protein concentrations of supernatant were determined by the Lowry method, and equal amounts of protein (50 μg) in laemmli sample buffer (Bio-Rad Laboratories) with ß-mercaptoethanol were boiled for 5 min. Proteins and molecular weight marker were resolved by 7% sodium dodecyl sulfate (SDS)-polyacrylamide gel (90 min, 100 V) and then electroblotted to nitrocellulose membranes. Membranes were blocked for 1 h at RT with 10% dry non-fat milk in Tris-buffered saline and incubated with primary antibodies: anti-c-Met (rabbit, polyclonal, Santa Cruz Biotechnology, Heidelberg, Germany) and anti-ASGPr (rabbit, polyclonal, kindly provided by U. Treichel, Essen) overnight at 4˚C. Both antibodies were diluted to 1:100 in Tris-buffered saline with 0.5% BSA. Membranes were washed and labeled with horseradish peroxidase (HRP)-conjugated secondary antibodies, goat anti-rabbit-IgG (1:5000, Biozol). Immunoreactivity was detected using a chemiluminescence Western blotting system (Chemiluminescence Detection kit, Amersham).
Receptor phosphorylation. Hepatocytes were maintained in serum and HGF/EGF-free DMEM F-12 for 24 h prior to stimulation in order to avoid any artefacts of protein phosphorylation due to serum and growth factors. Hepatocytes were stimulated for 3 min with 1 ng/ml HGF (R&D Systems, Wiesbaden, Germany). Subsequently, hepatocytes were rinsed with ice-cold PBS, lysed for 5 min in lysis buffer, and Western blot assay was carried out as described above. The monoclonal antibody, p-Tyr (Santa Cruz Biotechnology; clone PY99, 1:250 dilution), was used to detect ligandinduced tyrosine phosphorylation. The EGFr and c-Met expressing cell line, A431, served as the positive control.
Confocal laser-scanning microscopy. Hepatocytes were plated on 12-mm round cover slips (pretreated with collagen I) overnight. Cells were then washed and fixed with -20˚C methanole/ acetone ( V /V 60%/40%) followed by incubation on ice for 60 min with unconjugated antibody rabbit anti-c-Met (1:100, rabbit, polyclonal; Santa Cruz Biotechnology). Cells were washed twice before incubation with Cy3-conjugated goat anti-rabbit-IgG (1:50, Dianova) for 30 min on ice. To prevent photobleaching of the fluorescent dye, stained cells were mounted on slides with anti-fading reagent kit (ProLong™ Antifade Kit, MoBiTec, Göttingen, Germany). The slides were viewed using a confocal laser scanning microscope (LSM 10; Zeiss, Jena, Germany) with a planneofluor x100/1.3 oil immersion objective.
Statistical analysis. Data are expressed as mean ± SD. All experiments were performed 3-6 times. Statistical significance was investigated by the Wilcoxon-Mann-Whitney U test. Differences were considered statistically significant at p<0.05.
Results

Cirrhosis is accompanied by hepatocyte de-differentiation and c-Met elevation.
Hepatocytes that were cultivated on a two-dimensional collagen matrix in a differentiation medium generated a constant ASGPr level, which implies that cells remained differentiated throughout the period of experiment (Fig. 1A) . Additionally, the c-Met surface level did not change during the evaluation period (Fig. 1B) . Confocal analysis showed homogeneous distribution of localized ASGPr and c-Met receptors (Fig. 3) . Western blot analysis revealed equal amounts of ASGPr and c-Met proteins, even until day 5 of cell cultivation (Fig. 2) , contrary to the hepatocytes in a dedifferentiation medium, which resulted in a rapid loss of ASGPr, indicating the de-differentiation stage (Figs. 1A  and 2 ). Elevation of c-Met surface level was accompanied by a reduction in intracellular c-Met protein content (Figs. 1B  and 2 ).
To prove that the c-Met increase was indeed caused by soluble HGF, hepatocytes were cultivated under serum and HGF-free conditions and then activated by different concentrations of HGF, which was applied exogenously. Fig. 4 shows HGF-dependent c-Met up-regulation, whereby the amount of c-Met surface level correlated positively with the HGF concentration used.
Ursodeoxycholic and tauroursodeoxycholic acid protect hepatocytes from de-differentiation. Culturing hepatocytes in a cirrhosis representing milieu enriched with ursodeoxy- Table I . Cell culture media. 
g/l -------------------------------------------------
a ITS: rh-insulin 5.0 mg/l, human transferrin 5.0 mg/l, selenium 5.0 μg/l.
-------------------------------------------------
cholic or tauroursodeoxycholic acid significantly delayed the progression of hepatocyte de-differentiation (Fig. 5) . Tauroursodeoxycholic acid exerted stronger effects than ursodeoxycholic acid. Most impressively, the addition of tauroursodeoxycholic acid to the culture medium completely prevented the loss of ASGPr which was observed when hepatocytes were incubated in de-differentiation medium alone (Fig. 5A ). c-Met expression was altered only moderately under tauroursodeoxycholic acid (Fig. 5B) . Control experiments had been carried out in a normal milieu representative of a non-impaired liver, both ursodeoxycholic or tauroursodeoxycholic acid did not influence any changes in ASGPr and c-Met expression (data not shown).
Up-regulation of c-Met is accompanied by receptor nonresponsiveness.
Although the c-Met receptor was expressed very highly along the cell surface, it remained incapable of responding to soluble HGF. Fig. 2 demonstrates that c-Met lost the ability to become activated over time when hepatocytes were cultivated in a de-differentiation medium. Therefore, we prioritized an HGF-free environment (differentiation medium) to allow receptor phosphorylation (Fig. 2) .
A three-dimensional hepatocyte architecture promotes cell differentiation and c-Met responsiveness.
Cirrhosis is accompanied by distinct alterations in liver geometry. We analyzed if hepatocyte polarity contributes to cellular differentiation and c-Met responsiveness. Our results indeed showed that the ASGPr expression level remained constant over three days. Hepatocytes that were allowed to reorientate threedimensionally in a growth factor enriched extracellular environment (de-differentiation medium; Fig. 6A ) elicited a gradual reduction of ASGPr, in contrast to our observation in a two-dimensional collagen matrix, where a rapid loss of ASGPr was generated. A similar effect was also detected with ASGPr protein (Fig. 6A) . Therefore, the data indicate that at least a transient stabilization of the differentiation status is achieved in polar hepatocytes. The same phenomenon was observed with respect to c-Met. Both c-Met surface level and intracellular c-Met protein content did not change dramatically over a period of time in a threedimensional culture system (Figs. 6B and 7) .
The monoclonal antibody, p-Tyr, was used to detect ligand induced tyrosine phosphorylation. Interestingly, hepatocytes preserved their sensitivity to soluble HGF when threedimensional cell morphology was established, even under dedifferentiation inducing conditions (Fig. 7) .
Discussion
Proper liver architecture is crucial for hepatic function but is commonly disrupted in cirrhosis. In a liver cirrhosis model, marked and widespread signs of dysplasia, with nuclear pleomorphisms and initial loss of normal architecture were scored in mice exposed to ethanol but not in the control group (18) . The disturbance of architecture was accompanied by a progressive cellular de-differentiation, as revealed by an increase in gene expression for alpha-fetoprotein, hepatocyte growth factor, and c-myc (19) . Notably, c-Met receptor expression was detected in activated hepatic stellate cells while receptors remained undetectable in normal tissue (8) .
Our experiment demonstrates that a growth factor enriched extracellular milieu evokes hepatocyte de-differentiation paralleled by a rapid c-Met increase on the cell surface. Western blot data show down-regulation of the intracellular c-Met content. Collectively, these suggest a rapid c-Met translocation from the cytoplasm to the plasma membrane. Remarkably, enhanced c-Met presentation was not coupled with enhanced responsiveness to HGF. We speculate that up-regulation of c-Met, which indeed takes place during the development of fibrosis/cirrhosis, might induce a negative feedback mechanism which blocks outside-in signalling. Presumably, this process was caused in conjunction with an increased HGF level at the inflammatory site, and the c-Met non-responsiveness seems to protect hepatocytes from a permanent over-stimulation by HGF. Novel experiments truly present evidence of a negative feedback regulation in which c-Met activation leads to transcriptional induction of the Notch pathway which, in turn, limits HGF activity through repression of c-Met (20) .
Therefore, when discussing the therapeutic potential of HGF, it should be considered that c-Met is able to self-tune its own activity. Consequently, long-term application of HGF to treat cirrhosis might possibly evoke drug resistance. In this context, we restate that addition of bile salts to our culture system delayed the process of hepatocyte de-differentiation and c-Met elevation, whereby tauroursodeoxycholic acid demonstrated higher efficacy than ursodeoxycholic acid. Bile salts have already been shown to slow down the progression of primary biliary cirrhosis and improve a number of other cholestatic disorders (21) . Also relevant is the study of Caglieres et al (22) , which reported that treatment of tauroursodeoxycholic acid improved the biochemical parameters of cytolysis and cholestasis and maintained the functional stability of end-stage cirrhotic patients awaiting liver transplantation. Though the underlying mechanism is still not clear, there is Hepatocytes were seeded on a two-dimensional collagen matrix, incubated in an HGF and serum-free culture medium and then activated by various HGF concentrations ranging from 0.1 to 10 ng/ml. The receptor level was detected by flow cytometry and expressed as mean fluorescence units (MFU). Mean ± SD of n=6 experiments is shown. Receptor evaluation was carried out on days 1, 2 and 3 after plating. * Significant differences to unstimulated controls.
evidence that tauroursodeoxycholic acid is responsible for receptor tyrosine kinase activation and enhanced signalling down the ERK1/2 and AKT pathways (23) . Rao and coworkers identified the epidermal growth factor receptor as a possible target of tauroursodeoxycholic acid (24) . Our experiments identify the c-Met receptor. Although it has not yet been clearly proven, we speculate that tauroursodeoxycholic acid might (partially) revert c-Met non-responsiveness, either by re-activating the receptor or by activating alternate pathways.
In addition to alterations in the extracellular milieu, disorganization of the normal liver architecture also contributes to changes of c-Met. Our in vitro system indicates that embedding the hepatocytes within a three-dimensional matrix stabilizes c-Met activity and keeps the c-Met expression level constant. Our experimental observation correlated with the study of Tomita et al (25) who reported that the development of fibrosis in alcoholic liver diseases and break down of the liver architecture was accompanied by a down-regulation of c-Met activity.
In an earlier publication, we demonstrated that degradation of the extracellular liver matrix led to qualitative and quantitative alterations in the intermediate filament pattern of human hepatocytes. These alterations included reduced intracellular filament coordination, enhanced expression of cytokeratins 8 and 18, and de novo synthesis of cytokeratins 7 and 19 and vimentin (16) . It seems likely that destruction of the liver matrix changes the initial hepatocyte morphology, polarity and receptor equipment. Not only growth factor receptors should be considered as sensitive membrane elements; distribution of F-actin, E-cadherin, and apical and lateral membrane proteins also depend on hepatocellular architecture (26, 27) . We assume that the loss of cell geometry caused by degradation of the extracellular liver matrix, changes of their chemical composition and/or their molecular organization switches c-Met from HGF-sensitive to HGF-insensitive. Modifications of further membrane receptors as well as intracellular structures might accelerate the process of hepatocyte de-differentiation. Consequently, therapeutic modulation of the liver matrix might re-sensitize the c-Met receptor. However, pharmacological intervention should not only include the prevention of excessive collagen production (28, 29) but also the application of matrix proteins to re-establish the physiological matrix composition. Fibronectin administration has already been shown to prevent endotoxin-induced liver injury after partial hepatectomy in rats (30) . Exogenous administration of high molecular weight hyaluronan influenced liver injury induced by administration of concanavalin A (Con A) or Dgalactosamine/lipopolysaccharide (GalN/LPS) and cytokine production in mice (31) . Based on an in vitro assay, we reported that enrichment of the culture medium with fluid matrix proteins stabilized hepatocyte cultures and delayed de-differentiation events (32) .
In conclusion, our results demonstrate that cirrhosis is accompanied by an up-regulation of c-Met. However, c-Met receptors present at the hepatocyte cell surface remain insensitive to soluble HGF. This phenomenon might be caused by excessive HGF production and receptor over-stimulation. The switch from physiological to pathological cell morphology may contribute to a distinct blockade of c-Met dependent signals. Both events should be considered when establishing HGF-based therapy as a treatment for cirrhosis. Figure 6 . Influence of cell geometry on receptor expression. Hepatocytes were cultivated in a three-dimensional collagen sandwich either in differentiation medium (D) or in de-differentiation medium (DeD) representing cirrhotic conditions. The surface receptor level was detected by flow cytometry and expressed as mean fluorescence units (MFU). Mean ± SD, (n=6). Fluorometry was carried out on days 1, 3, 5 and 7 after plating.
* Statistically significant differences. Figure 7 . Influence of cell geometry on receptor content and c-Met activity. Hepatocytes were incubated within a three-dimensional collagen gel in chemically defined differentiation medium or in de-differentiation medium representing cirrhotic conditions. The protein content was analyzed on day 1, 3 or 5 after plating the hepatocytes. D, cultivation in differentiation medium; DeD, cultivation in de-differentiation medium. ß-actin served as the internal control. The figure shown is re-presentative of three separate experiments.
